Nouvelles

Nouvelles

Reaction positive as Health Canada proposes allowing doctors to prescribe heroin

dimanche, 15 mai 2016

Health officials in B.C. are applauding the federal government for taking steps to allow doctors to prescribe heroin for certain patients. 

Valeant forms committee on drug prices

jeudi, 12 mai 2016

LAVAL, Que. - Embattled drug manufacturer Valeant Pharmaceuticals International (TSX:VRX) is revamping the way it prices drugs. 

Scientific basis for laws on marijuana, driving questioned - The Northern View

mardi, 10 mai 2016

 The Northern View -WASHINGTON — Six states that allow marijuana use have legal tests to determine driving while impaired by the drug that have no scientific basis, according to a study by the nation's largest automobile club that calls for scrapping those laws. 

Canadian Employers Will Face a $5.6 Billion Price Tag for Specialty Drugs Within the Next Five Years

mardi, 10 mai 2016

Le Lezard (EN) - Express Scripts Canada, one of the country's leading providers of health benefits management services, today announced the results of its annual Drug Trend Report. 

Germany To Legalize Medical Marijuana Next Year

dimanche, 8 mai 2016

IFL Science - Germany is set to become the latest country to legalize the use of cannabis for medicinal purposes, with the nation’s health minister confirming earlier this week that the German cabinet had approved the move. 

Valeant Pharmaceuticals announces shakeup on its board of directors

vendredi, 6 mai 2016

Valeant Pharmaceuticals is shaking up its board of directors, with half of them not standing for re-election, the Quebec-based drugmaker announced Friday. 

Concordia Healthcare: Diving deep into claims of sky high prices

vendredi, 6 mai 2016

BNN - Business News Network - Anyone with a passing interest in healthcare knows the practice of drug price increases has come under scrutiny lately. Concerns around this scrutiny evolving into new regulations or legal troubles have wiped out stock values in the process. 

Valeant is going to review how it sets prices for drugs (May 06, 2016 )

vendredi, 6 mai 2016

CTV Montreal News - Embattled drug manufacturer Valeant Pharmaceuticals International (TSX:VRX) is revamping the way it prices drugs.
The company issued a statement late Thursday saying it is forming a new "patient access and pricing committee" that will be responsible for what it charges for prescription drugs. 

FDA takes significant steps to protect Americans from dangers of tobacco through new regulation

jeudi, 5 mai 2016

Le Lezard (EN) - The U.S. Food and Drug Administration finalized a rule extending its authority to all tobacco products, including e-cigarettes, cigars, hookah tobacco and pipe tobacco, among others.  

Warren Buffett calls Valeant strategy 'flawed'

lundi, 2 mai 2016

Toronto - CBC News - Investor Warren Buffett said Berkshire Hathaway has called the business model of Valeant Pharmaceuticals flawed and panned the company's leadership. 

Displaying results 61-70 (of 72)
 |<  <  1 - 2 - 3 - 4 - 5 - 6 - 7 - 8  >  >| 

Member Forum

15 septembre 2020
Angus Glen Golf Club
Markham, Ontario

PLUS D’INFO

2019 Technology Boot Camp

20 novembre 2019
Sheraton Toronto Airport Hotel & Conference Centre
Toronto

PLUS D’INFO

Executive Conference

13 - 14 janvier 2020
Hôtel Marriott Terminal Aéroport de Montréal
Dorval, QC

PLUS D’INFO

Annual Conference

3 - 6 mai 2020
JW MARRIOTT NASHVILLE
Nashville, Tennessee

PLUS D’INFO